Samsung Medison is making waves at the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2025) in Cancún, unveiling its upgraded HERA Z20 ultrasound system that promises to transform women's healthcare from adolescence through menopause. The AI-powered platform represents Samsung's bold push into the $8.2 billion ultrasound market, targeting healthcare providers struggling with complex diagnostic workflows and rising maternal health risks.
Samsung just dropped a healthcare bombshell at ISUOG 2025 that could reshape how doctors approach women's health diagnostics. The Korean tech giant's medical division is showcasing its upgraded HERA Z20 ultrasound system in Cancún, and the timing couldn't be better as maternal health challenges mount globally.
The centerpiece of Samsung's "From Challenges to Solutions" exhibition is the HERA Z20's comprehensive approach to women's health across all life stages. Unlike traditional ultrasound systems that require multiple specialized devices, Samsung's platform promises to handle everything from adolescent gynecological conditions to high-risk pregnancies and menopause-related diagnostics with a single machine.
"The Upgraded HERA 20 is more than just equipment enhancement - it's a total solution designed to support women's health across all life stages," Jihyun Kim, Head of the CX group at Samsung Medison told attendees. "By combining AI technology with healthcare professionals' clinical experience, we aim to enhance diagnostic accuracy and reduce burdens."
The AI integration runs deep. Samsung's newly introduced PelvicAssist™ automatically analyzes multiple pelvic regions and measures the levator hiatus area while generating 3D images - a process that traditionally requires significant manual expertise and time. The system's three specialized reporting features address the complexity healthcare providers face when assessing lesion location, size, shape, and invasion degree.
What's particularly striking is Samsung's focus on workflow efficiency. The Fibroid 2D feature simplifies uterine fibroid reporting by applying International Federation of Gynecology and Obstetrics (FIGO) guidelines automatically. Meanwhile, IDEA and IETA features streamline endometriosis and endometrial tumor evaluation by supporting standardized scan procedures and reporting.
The hardware innovation is equally impressive. Samsung's ultra-compact Mini ER7 probe features a 63% smaller head compared to conventional probes, specifically designed to minimize patient discomfort during gynecological examinations. This addresses a significant barrier to care, particularly for adolescent and elderly patients who often experience heightened anxiety during such procedures.